WallStreetZenWallStreetZen

NYSEMKT: VTAK
Catheter Precision Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their VTAK stock forecasts and price targets.

Forecast return on equity

Is VTAK forecast to generate an efficient return?

Company
-8.03%
Industry
15.85%
Market
328.57%
VTAK's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VTAK forecast to generate an efficient return on assets?

Company
-2.14%
Industry
10.03%
VTAK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VTAK earnings per share forecast

What is VTAK's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.64-101.93%
Avg 2 year Forecast
-$0.33-100.98%

VTAK revenue forecast

What is VTAK's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$3.9M+430.96%
Avg 2 year Forecast
$10.4M+1,325.21%
VTAK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VTAK revenue growth forecast

How is VTAK forecast to perform vs Medical Devices companies and vs the US market?

Company
430.96%
Industry
3.75%
Market
1,444.25%
VTAK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VTAK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VTAK vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
VTAK$2.12N/AN/A
VERO$1.98N/AN/A
AEMD$4.44$15.00+237.84%Hold
TIVC$1.82N/AN/A
NUWE$2.44N/AN/A
View Top Medical Device Stocks

Catheter Precision Stock Forecast FAQ

What is VTAK's earnings growth forecast for 2025-2026?

(NYSEMKT: VTAK) Catheter Precision's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 26.82%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,927.49%.

Catheter Precision's earnings in 2025 is -$22,191,000.On average, 3 Wall Street analysts forecast VTAK's earnings for 2025 to be -$1,072,098, with the lowest VTAK earnings forecast at -$1,030,055, and the highest VTAK earnings forecast at -$1,103,630.

In 2026, VTAK is forecast to generate -$544,558 in earnings, with the lowest earnings forecast at -$523,202 and the highest earnings forecast at -$560,574.

If you're new to stock investing, here's how to buy Catheter Precision stock.

What is VTAK's revenue growth forecast for 2025-2026?

(NYSEMKT: VTAK) Catheter Precision's forecast annual revenue growth rate of 430.96% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 3.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,444.25%.

Catheter Precision's revenue in 2025 is $730,000.On average, 3 Wall Street analysts forecast VTAK's revenue for 2025 to be $6,466,622, with the lowest VTAK revenue forecast at $6,213,029, and the highest VTAK revenue forecast at $6,656,816.

In 2026, VTAK is forecast to generate $17,357,774 in revenue, with the lowest revenue forecast at $16,677,077 and the highest revenue forecast at $17,868,296.

What is VTAK's forecast return on assets (ROA) for 2025-2026?

(NYSEMKT: VTAK) forecast ROA is -2.14%, which is lower than the forecast US Medical Devices industry average of 10.03%.

What is VTAK's Earnings Per Share (EPS) forecast for 2025-2026?

(NYSEMKT: VTAK) Catheter Precision's current Earnings Per Share (EPS) is $33.30. On average, analysts forecast that VTAK's EPS will be -$0.64 for 2025, with the lowest EPS forecast at -$0.62, and the highest EPS forecast at -$0.66. In 2026, VTAK's EPS is forecast to hit -$0.33 (min: -$0.31, max: -$0.34).

What is VTAK's forecast return on equity (ROE) for 2025-2026?

(NYSEMKT: VTAK) forecast ROE is -8.03%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.